Global Women’s Health Drugs Market to 2024 – Influx of New Products Including Orilissa, Relugolix and Bremelanotide

Global Women’s Health Drugs Market to 2024 Research Report provides Key Marketed Products, Pipeline Landscape Assessment, Company Analysis and Positioning, Revenue and Market Share and Strategic Consolidations.

Pune, India - February 12, 2019 /MarketersMedia/ —

The women’s health therapy area covers medical disorders that affect females only, primarily disorders of the female reproductive system, including those associated with menstruation, conception, pregnancy, childbirth and menopause. Many of these disorders are highly prevalent among the female population.

The Women’s Health Market is relatively small considering the high prevalence of many women’s health indications. However, robust growth is projected over the forecast period due to the influx of a number of new products.

This report covers all indications within women’s health with a particular focus on five key indications: endometriosis, polycystic ovarian syndrome (PCOS), cervical intraepithelial neoplasia (CIN), menopausal disorders and infertility.

*Company Analysis and Positioning:
Revenue and Market Share Analysis by Company
1 Bayer AG - Company to Remain a Market Leader within Women’s Health
2 AbbVie Inc - Orilissa to Reach Blockbuster Status, Boosting Company’s Market Share
3 Allergan - Revenue Gains From Fibristal, Lo Loestrin Fe and Liletta to Offset Losses from Minastrin 24 Fe and Estrace
4 Merck & Co. - Company to Remain a Key Player Due to Growth of Gardasil/Gardasil 9
5 GlaxoSmithKline - Cervarix and Retosiban to Drive Strong Growth
6 Pfizer - How will patent expiration affect revenues for women’s health market?
7 TherapeuticsMD – Women’s Health Specialist to Gain Considerable Market Share by 2024

Get Discount on Global Women’s Health Drugs Market Research Report at https://www.reportsnreports.com/contacts/discount.aspx?name=1854865

Scope
- There are 277 pipeline products in active development for women’s health disorders. Which molecule types and molecular targets are most prominent within the pipeline?
- Merck&Co and Bayer currently represent leading companies within women’s health. Will they maintain this dominance over the forecast period?
- Gardasil, Mirena and Nuvaring and are among the most lucrative drugs within the women’s health market. Which of these will experience a considerable decline in revenue over the forecast period following loss of patent protection?
- The influx of a number of recent market entrants and late-stage pipeline products will have a considerable impact on the women’s health market over the forecast period. Which of these drugs are projected to achieve blockbuster status by 2024?
- In total, 246 licensing deals relating to women’s health products have been completed since 2006. Which types of assets attracted the largest deal values?

Direct Purchase of this Research Report at https://www.reportsnreports.com/purchase.aspx?name=1854865

Reasons to buy:
- Understand the current treatment landscape, with portfolios of key marketed products and a focus on historical and forecast sales patterns, and an overview of each drug’s mechanism of action.
- Analyze the women’s health pipeline through a comprehensive review of the pipeline segmented by stage of development, molecule type and molecular target.
- Consider market opportunities and potential risks by examining trends in clinical trial duration and size, as well as clinical trial failure rates.
- Predict growth in market size by examining multi-scenario forecasting trends from 2017 to 2024 and determine the contributions that different products and companies will make to this growth.
- Identify commercial opportunities in the women’s health deals landscape by analyzing trends in licensing and co-development deals.

Contact Info:
Name: Vishal Kalra
Email: Send Email
Organization: ReportsnReports
Website: https://www.reportsnreports.com/reports/1854865-global-womens-health-drugs-market-to-2024-influx-of-new-products-including-orilissa-relugolix-and-bremelanotide-to-diversify-landscape-and-drive-growth.html

Source URL: https://marketersmedia.com/global-womens-health-drugs-market-to-2024-influx-of-new-products-including-orilissa-relugolix-and-bremelanotide/481772

Source: MarketersMedia

Release ID: 481772

Latest News

Chelsea coach Sarri looking for run of wins to appease fans

Feb 21, 2019

LONDON — Chelsea coach Maurizio Sarri says he needs a run of wins to get the club's fans back on his side after a series of bad results. The Italian, who was subjected to abuse from Chelsea supporters after the side's FA Cup exit to Manchester United on Sunday, says: "We need to win three, four matches in a row. It's the only solution." Chelsea's next three games — Thursday's Europa League last-32 second leg against Malmo, Sunday's Carabao Cup final against Manchester City and then the Premier League meeting with crosstown rival Tottenham —could determine whether Sarri will stay...

Unlike men's World Cup, no open vote on women's event host

Feb 21, 2019

LONDON — FIFA will still decide the host of the Women's World Cup in secret, unlike the new open vote held last year for host of the 2026 men's tournament. The 2023 Women's World Cup bidding process was launched Tuesday, and FIFA adopted many of the rigorous checks and scrutiny that prospective men's hosts now have to go through. But the final decision is a very different process. Following corruption investigations into the vote for men's hosts in 2018 and 2022, FIFA removed the decision from its ruling committee and gave it to all member associations. When it came to...

Maurizio Sarri isolated at Chelsea after fans turn on him

Feb 21, 2019

LONDON — The volley of abusive chants from Chelsea supporters were aimed in a different direction this time. Toward the sideline at Stamford Bridge. Players were spared on Monday, there was no need to dig out the "rats" banners from 2015, and supporters seem just fine with Eden Hazard and Co. Typically loyal to their managers — and there have been a dozen alone this century — many Chelsea fans instead seem to be done with Maurizio Sarri even before the end of his first season in charge. Losing in the FA Cup to Manchester United was the breaking point,...

Man United defeats Chelsea, advances to FA Cup quarterfinals

Feb 21, 2019

LONDON — Ander Herrera and Paul Pogba each scored first-half goals as Manchester United defeated Chelsea 2-0 on Monday at Stamford Bridge to advance to the quarterfinals of the FA Cup. United, which has lost just once in interim manager Ole Gunnar Solskjaer's 13 games in charge, has reached the quarterfinals of the competition for the fifth consecutive season. A rematch of last year's final won by Chelsea, Herrera put United ahead in the 31st minute and Pogba came through just before halftime to double the lead. United had not played since losing 2-0 to Paris Saint-Germain in the opening...

Wolverhampton hangs on to beat Bristol City in FA Cup

Feb 21, 2019

LONDON — Wolverhampton held on to beat Championship side Bristol City 1-0 to reach the quarterfinals of the FA Cup on Sunday. The second-tier team threatened from a series of set-pieces late in the game but could not find an equalizer against their Premier League opponents who took the lead in the 28th minute through Ivan Cavaleiro. Cavaleiro, one of three changes to the Wolves line-up, was left in space to fire in Matt Doherty's cutback with what was the first shot of the game at Ashton Gate. Bristol goalkeeper Frank Fielding joined the attack during a late corner but...

About Us

Frontal Report is an emerging leader in all forms of media. We aim to be the leading news brand for readers around the world.

Contact us: sales[at]frontalreport.com

Subscribe Now!